Ingalfarma performs product tests on COVID-19 patients connected to mechanical ventilators, to treat oral lesions caused by connection to respirators, helping to lessen these adverse effects and help to recover, as soon as possible, their normal diet.
«At Ingalfarma, we always want to contribute from the medical perspective of comprehensive management, in the recovery of patients and their quality of life. It is not pretentious to affirm that a mouth without damage will allow a normal diet and an adequate recovery. In this context, Dentoxol® is an effective tool to heal lesions of the oral mucosa, from the moment of the patient’s extubation.”